Deferoxamine
In Stock•Starting at $160 for 25 mg•Purity ≥ 98%
| CAS No. | 70-51-9 |
|---|---|
| MDL No. | MFCD00242585 |
| MF | C25H48N6O8 |
| MW | 560.70 |
| InChI Key | UBQYURCVBFRUQT-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 25 mg | 98% | $160 | In Stock | |
| 50 mg | 98% | $285 | In Stock | |
| 100 mg | 98% | $483 | In Stock | |
| 250 mg | 98% | $818 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Desferrioxamine B is an acyclic desferrioxamine derived from butanedioic acid. One carboxy group undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide, while the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore produced by *Streptomyces pilosus* via the DesABCD enzyme cluster, functioning as a high-affinity Fe(III) chelator. It acts as an iron chelator, siderophore, ferroptosis inhibitor, and bacterial metabolite. It is the conjugate base of desferrioxamine B(1+) and the conjugate acid of desferrioxamine B(3-).
| CAS No. | 70-51-9 |
|---|---|
| Product Name | Deferoxamine |
Associated Conditions
intracerebral hemorrhage·diabetic foot·Thalassemia·subarachnoid hemorrhage·sickle cell disease·
* The information provided here is compiled from public sources and is for reference only.
